Pharma and biotech companies are increasingly using saliva for clinical trials and drug response studies, thanks to its non-invasive nature and ease of repeated sampling. Dentistry, too, is leveraging ...

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?

The man accused of abducting, sexually assaulting and murdering Beverly Wivell over 35 years ago is expected to appear in ...

The man accused of abducting, sexually assaulting and murdering Beverly Wivell over 35 years ago is expected to appear in ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

Pharmaceutical giant Regeneron has promised to prioritise the “ethical use” of the sequenced DNA data of more than 15 million ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Drugmaker Regeneron Pharmaceuticals says it will comply with privacy policies regarding the use of customer data. 23andMe's ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

Regeneron Pharmaceuticals has bought the genetic testing company 23andMe, a company once valued at $6bn, for $256m through a ...

Announcing the $256 million deal, the New York-based biotech firm vowed to comply with 23andMe’s privacy policy, which was a ...